Consequently, we hypothesized that SESN2 may exert a tumor-suppressive role in PCa and that the MTDH-SND1 complex targets SESN2 mRNA for degradation, thereby promoting PCa progression. The gene discussed is SND1; the disease is posterior cortical atrophy.